CIK 0001070494 · Large accelerated filer
ACADIA PHARMACEUTICALS INC
Sign in to watch- Ticker
- ACAD
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 061376651
- Phone
- 858-558-2871
- Business address
- 12830 EL CAMINO REAL, SUITE 400, SAN DIEGO, CA, 92130
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $69,342
- in 1 filing
Net −$69,342. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-03-25 | Schneyer Mark C. EVP, CHIEF FINANCIAL OFFICER | Option exercise | +6,178 | 60,060 | ||
| 2025-03-25 | Schneyer Mark C. EVP, CHIEF FINANCIAL OFFICER | Option exercise · Restricted Stock Units | −6,178 | 18,536 | ||
| 2025-03-24 | Kihara James PRINCIPAL ACCOUNTING OFFICER | Grant or award · Stock Option (Right to Buy) | +22,152 | 22,152 | ||
| 2025-03-24 | Kihara James PRINCIPAL ACCOUNTING OFFICER | Grant or award · Restricted Stock Units | +6,510 | 6,510 | ||
| 2025-03-24 | Schneyer Mark C. EVP, CHIEF FINANCIAL OFFICER | Grant or award · Stock Option (Right to Buy) | +110,761 | 110,761 | ||
| 2025-03-24 | Schneyer Mark C. EVP, CHIEF FINANCIAL OFFICER | Grant or award · Restricted Stock Units | +32,552 | 32,552 | ||
| 2025-03-24 | Rhodes Jennifer J EVP, CHIEF LEGAL OFFICER, SEC | Grant or award · Stock Option (Right to Buy) | +102,289 | 102,289 | ||
| 2025-03-24 | Rhodes Jennifer J EVP, CHIEF LEGAL OFFICER, SEC | Grant or award · Restricted Stock Units | +30,062 | 30,062 | ||
| 2025-03-24 | Thompson Elizabeth H.Z. EVP, Head of Research & Dev | Grant or award · Stock Option (Right to Buy) | +91,395 | 91,395 | ||
| 2025-03-24 | Thompson Elizabeth H.Z. EVP, Head of Research & Dev | Grant or award · Restricted Stock Units | +26,861 | 26,861 | ||
| 2025-03-24 | Owen Adams Catherine Chief Executive Officer | Grant or award · Stock Option (Right to Buy) | +319,976 | 319,976 | ||
| 2025-03-24 | Owen Adams Catherine Chief Executive Officer | Grant or award · Restricted Stock Units | +94,039 | 94,039 | ||
| 2025-03-05 | GAROFALO ELIZABETH A. Director | Sale | −4,919 | $18.23 | $90K | 17,595 |
| 2025-02-24 | Kihara James PRINCIPAL ACCOUNTING OFFICER | Sale | −475 | $19.96 | $9K | 20,228 |
| 2025-02-24 | Schneyer Mark C. EVP, CHIEF FINANCIAL OFFICER | Sale | −773 | $19.96 | $15K | 53,882 |
| 2025-02-23 | Kihara James PRINCIPAL ACCOUNTING OFFICER | Option exercise | +840 | 20,703 | ||
| 2025-02-23 | Kihara James PRINCIPAL ACCOUNTING OFFICER | Option exercise · Restricted Stock Units | −840 | 0 | ||
| 2025-02-23 | Schneyer Mark C. EVP, CHIEF FINANCIAL OFFICER | Option exercise | +1,353 | 54,655 | ||
| 2025-02-23 | Schneyer Mark C. EVP, CHIEF FINANCIAL OFFICER | Option exercise · Restricted Stock Units | −1,353 | 0 | ||
| 2024-12-09 | Garner Thomas EVP, Chief Commercial Officer | Grant or award · Stock Option (Right to Buy) | +235,849 | 235,849 |
Page 9 of 63 · 1,260 trades